亚组分析 | 例数 | CR (例) | PR (例) | SD (例) | PD (例) | ORR (%) | DCR (%) | χ2 | p值 |
分子亚型 |
|
|
|
|
|
|
| 5.537 | 0.223 |
三阴性 | 14 | 0 | 4 | 9 | 1 | 28.6 | 92.9 |
|
|
Lunminal型 | 9 | 0 | 2 | 5 | 2 | 22.2 | 77.8 |
|
|
HER-2过表达型 | 5 | 0 | 0 | 2 | 3 | 0.0 | 40.0 |
|
|
优替德隆治疗线数 |
|
|
|
|
|
|
| 6.180 | 0.172 |
≤三线治疗 | 11 | 0 | 3 | 8 | 0 | 27.3 | 100.0 |
|
|
≥四线治疗 | 17 | 0 | 3 | 8 | 4 | 17.6 | 64.7 |
|
|
年龄(岁) |
|
|
|
|
|
|
| 0.627 | 0.878 |
<50 | 15 | 0 | 4 | 8 | 3 | 26.7 | 80.0 |
|
|
≥50 | 13 | 0 | 2 | 8 | 3 | 15.4 | 76.9 |
|
|